JSB Market Research

  The global market for media, sera and reagents in biotechnology was estimated at nearly REDACTED in 2017, growing at a compound annual growth rate (CAGR) of REDACTED to reach around REDACTED by 2023. Based on product segment, cell culture reagents are expected to grow at the industry's highest rate, followed by the media segment, thanks to innovative media formulation in the serum-free media category, which will augment the demand for reagents such as growth factors, cytokines and other growth supplements. The market for sera is anticipated to grow at a steady rate owing to high prices and the unavailability of quality sera coupled with growing preference for serum-free media from biopharmaceutical productions.                                                                        Get Free Sample Report:                                                       Media, Sera and Reagents in Biotechnology Market Summary The current report provides detailed exposure of media, se

Summary: Larsen & Toubro Limited (L&T) is an industry conglomerate which carries out technology, engineering, construction and manufacturing activities. It offers a broad spectrum of design-to-deliver solutions. Its service portfolio includes basic and detailed engineering, erection and commissioning, equipment fabrication and supply, procurement and construction, and project management. The company offers these services to various sectors, including infrastructure, hydrocarbon, power, defense, aerospace, construction, shipbuilding, mining and metallurgy. The company also manufactures and distributes construction and mining equipment, and products for electricity distribution and control. L&T also provides finance related services such as corporate finance, equipment finance, infrastructure finance, general insurance and related advisory services. It has operations in the Middle East and North Africa (MENA), South East Asia and Europe. L&T is headquartered in Mumba

Synopsis "HHNHS Winchester Hospital Development Hampshire - Project Profile" contains information on the scope of the project including project overview and location. The profile also details project ownership and funding, gives a full project description, as well as information on contracts, tendering and key project contacts. The "HHNHS Winchester Hospital Development Hampshire - Project Profile" is part of 1 database of 82,000+ construction projects. Our database includes a 10+ year archive of completed projects, full coverage of all global projects with a value greater than $25 million and key contact details for project managers, owners, consultants, contractors and bidders. Summary The Hampshire Hospitals NHS Foundation Trust (HHNHS) is undertaking the Winchester Hospital project in Hampshire, the UK. The project involves the construction of a 34,000m2, 360-bed Critical Treatment Hospital and a 6,500m2 Cancer Treatment Centre on 22ha of land. It inclu

Summary The global pharmaceutical excipients market reached nearly $REDACTED billion in 2016 and is expected to grow at a REDACTED% compound annual growth rate (CAGR) over the next five years, driven by the increase in demand for oleochemicals and petrochemicals, to reach a value of $REDACTED billion in 2022.                                                                   Get Free Sample Report:                                                 Excipients in Pharmaceuticals: Global Markets to 2022 Report Scope This report on the pharmaceutical excipient market covers an overview of excipients, classification of excipients, and their significance in the pharmaceutical industry. A detailed analysis illustrating market dynamics, market structure analysis incorporating Porters Five Force Framework analysis and supply chain and distribution is discussed in detail. Excluded from the scope of this report is the use of excipients in cosmetics, food and beverage, and chemical industri

Summary: The market for third-party commercial “Internet of Things” (IoT) platforms is rapidly growing. The Market for these software-based platforms, estimated to be $REDACTED million globally in 2017, is expected to grow at a healthy REDACTED% annualized growth rate and exceed $REDACTED billion globally by 2023. Three different categories of IoT platforms have been designed to address diverse needs: device management and controls (Device Management Platforms), applications (Application Enablement Platforms) and network control centers for communication between devices and backend systems (Network Connectivity Management Platforms). In their initial stages of development, most IoT platforms provided one of the above capabilities, but with technology advancement there has been a gradual pivoting of most vendors to horizontal, module based platforms which can be a complete integrated end-to-end solution. Research predicts that this trend will continue to grow as demand for niche

Summary This report provides an overview of the Sickle Cell Disease pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for sickle cell anemia and vaso-occlusive crisis associated with sickle cell disease, and features dormant and discontinued projects. Sickle cell anemia is a genetic (inherited) blood disorder in which red blood cells, which carry oxygen around the body, develop abnormally. Signs and symptoms include anemia, delayed growth, vision problems, pain and frequent infections. There are a total of 62 products in development for this indication, by 45 companies and nine academic institutions. Hemoglobin and a range of histone deacetylases are the most common molecular targets being studied in sickle cell anemia. Vaso-occlusive crisis associated with sickle cell disease is a painful episode that occurs in people who have sickle cell anemia. Symptoms include fever, pain,